Laryngeal papillomatosis

Summary

Laryngeal papillomatosis (MONDO:0023597) is a disease and 2 clinical trials. A subtype of benign laryngeal neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	laryngeal papillomatosis
Mondo ID	MONDO:0023597
MeSH	C537876
NCIT	C157733
SNOMED CT	232457008
UMLS	C0396072
MedGen	96006
GARD	0006864
Is cancer (heuristic)	no

Also known as: juvenile laryngeal papillomatosis · juvenile laryngeal papillomatosis (subtype) · laryngeal papillomatosis · recurrent laryngeal papillomatosis · recurrent laryngeal papillomatosis (subtype) · Warts in the throat

Disease family

This is a subtype of benign laryngeal neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › respiratory system benign neoplasm › benign laryngeal neoplasm › laryngeal papillomatosis

Related subtypes (5): laryngeal leiomyoma, larynx squamous papilloma, benign neoplasm of epiglottis, benign neoplasm of glottis, benign neoplasm of subglottis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01793168	Not specified	RECRUITING	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT01304966	Not specified	COMPLETED	Human Papillomatosis Genotyping of Children in Thailand